Folic acid antagonist use before and during pregnancy and risk for selected birth defects.

Kerr, Stephen M; Parker, Samantha E; Mitchell, Allen A; Tinker, Sarah C; Werler, Martha M

Kerr, Stephen M; Parker, Samantha E; Mitchell, Allen A; Tinker, Sarah C; Werler, Martha M.

Afiliación

Kerr SM; Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
Parker SE; Department of Epidemiology, Boston University, Boston, Massachusetts, USA.
Mitchell AA; Slone Epidemiology Center at Boston University, Boston, Massachusetts, USA.
Tinker SC; Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, Georgia, USA.
Werler MM; Department of Epidemiology, Boston University, Boston, Massachusetts, USA.

Birth Defects Res ; 112(18): 1526-1540, 2020 11.

Article en En | MEDLINE | ID: mdl-32875745

Asunto(s)

Antagonistas del Ácido Fólico; Defectos del Tubo Neural; Estudios de Casos y Controles; Femenino; Ácido Fólico; Humanos; Defectos del Tubo Neural/epidemiología; Defectos del Tubo Neural/prevención & control; Oportunidad Relativa; Embarazo

Palabras clave

anti-epileptic drugs; birth defects; folic acid; folic acid antagonists; pregnancy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antagonistas del Ácido Fólico / Defectos del Tubo Neural Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Birth Defects Res Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google